US826029A - Rarefied-air apparatus for the treatment of pulmonary tuberculosis. - Google Patents

Rarefied-air apparatus for the treatment of pulmonary tuberculosis. Download PDF

Info

Publication number
US826029A
US826029A US23376604A US1904233766A US826029A US 826029 A US826029 A US 826029A US 23376604 A US23376604 A US 23376604A US 1904233766 A US1904233766 A US 1904233766A US 826029 A US826029 A US 826029A
Authority
US
United States
Prior art keywords
air
treatment
rarefied
cabinet
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US23376604A
Inventor
James Edward Harper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US23376604A priority Critical patent/US826029A/en
Application granted granted Critical
Publication of US826029A publication Critical patent/US826029A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G10/00—Treatment rooms or enclosures for medical purposes
    • A61G10/02—Treatment rooms or enclosures for medical purposes with artificial climate; with means to maintain a desired pressure, e.g. for germ-free rooms
    • A61G10/023—Rooms for the treatment of patients at over- or under-pressure or at a variable pressure
    • A61G10/026—Rooms for the treatment of patients at over- or under-pressure or at a variable pressure for hyperbaric oxygen therapy

Definitions

  • This invention consists of an apparatus designed especially for treatment of tuberculosis or pulmonary diseases of a similar na-
  • the benefit generally derived by persons afflicted with diseases of this character through living in high altitudes is chiefly due to the reduction of external pressure because of the rarefaotion of the air, such condition of the atmosphere inducing deep respirations, developing the lungs, and promoting circulation of the blood and lymph by increase or more free expansion of the chest.
  • Figure 1 is a perspective view of the apparatus embodying the invention.
  • Fig. 2 is a vertical sectional view of the invention.
  • a suitable cell or cabinet A is used, the construction of which makes the same practically air-tight, this being necessary in securing the beneficial results accomplished by use of the invention.
  • the cell or cabinet A is of a size sufficient to receive a person either in standing or sitting posture and is provided With a door B and a transparent side or Window 0.
  • An inlet-tube F leads through a side of the cell or cabinet A and is provided with a valve G,
  • the patient in the cell A inhales the rarefied air within this cell and exhales through the tube D, leading to the exterior atmosphere.
  • the patient himself therefore forms a pump in securing the rarefaction of the air, since the exhalations of the person being treated may be greater with regard to the quantity of air forced from the cell than the amount of air which is being admitted through the inlettube F.
  • the valve G regulates the amount of air passing into the cell through the tube F, the latter also may serve as a medium for administering medicine to the patient in the cell by medicating air, if necessary, by passing it through a thin screen upon which a volatile medicament may be spread.
  • the cell or cabinet A may have a suitable barometer or gage E of any suitable nature for determining the atmospheric pressure Within the cell to facilitate regulation thereof in the customary manner.
  • the herein-described rarefied-air apparatus for the treatment of pulmonary tuberculosis comprising an air-tight cell or cabinet, an inlet-tube F extending through one wall of the cabinet and provided on its inner end with a hand-operatedvalve G whereby the flow of air into the cabinet may be regulated by the patient, the saidtube being designed to admit air into the cabinet, the outer end of said tube F being bell-shaped and being provided with a thin screen, and a volatile medicament spread upon said screen whereby the air admitted from said tube and controlled by said valve will be medicated as it passes to the patient, and an exhaling-tube D leading from the interior of the cabinet to the exterior atmosphere and being so located in the cabinet that it will be in convenient location for the patient to exhale the air therethrough that has been inhaled in the cabinet.

Description

PATENTED JULY 17, 1906. J. E. HARPER.
RAREFIED AIR APPARATUS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS. APPLICATION FILED NOV.21.1904.
ture.
UNITED STATES PATENT OFFICE.
JAMES EDWARD HARPER, OF ASSUMPTION, ILLINOIS.
RAREFlED-AIR APPARATUS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS.
Specification of Letters'latent.
Patented July 17', 1906.
To all whom, it may concern:
Be it known that I, JAMES EDWARD HAR- PER, a citizen of the United States, residing at Assumption, in the county of Christian and State Illinois, have invented an entirely new apparatus known as the Rarefied-Air Apparatus for the Treatment of Pulmonary Tuberculosis, of which the following is a specification.
This invention consists of an apparatus designed especially for treatment of tuberculosis or pulmonary diseases of a similar na- The benefit generally derived by persons afflicted with diseases of this character through living in high altitudes is chiefly due to the reduction of external pressure because of the rarefaotion of the air, such condition of the atmosphere inducing deep respirations, developing the lungs, and promoting circulation of the blood and lymph by increase or more free expansion of the chest.
For a full description of the invention and the merits thereof and also to acquire a knowledge of the details of construction of the means for effecting the result reference is to be had to the following description and accompanying drawings, in which Figure 1 is a perspective view of the apparatus embodying the invention. Fig. 2 is a vertical sectional view of the invention.
Corresponding and like parts are referred to in the following description and indicated in all the views of the drawings by the same reference characters.
In carrying out the invention a suitable cell or cabinet A is used, the construction of which makes the same practically air-tight, this being necessary in securing the beneficial results accomplished by use of the invention. The cell or cabinet A is of a size sufficient to receive a person either in standing or sitting posture and is provided With a door B and a transparent side or Window 0.
In the practical use of the apparatus it is designed that the air within the cell or cabinet A be withdrawn, so as to rarefy the same, a partial vacuum being created therein in order to reduce the external or bodily atmospheric pressure, the person being treated exhaling the air inhaled in the cell or cabinet A through a tube D, which communicates with the atmospheric exterior of the cabinet A,
passing through a side of the latter. An inlet-tube F leads through a side of the cell or cabinet A and is provided with a valve G,
which may be operated to regulate the amount of air passing into the cell in a manner which will be obvious. The patient in the cell A inhales the rarefied air within this cell and exhales through the tube D, leading to the exterior atmosphere. The patient himself therefore forms a pump in securing the rarefaction of the air, since the exhalations of the person being treated may be greater with regard to the quantity of air forced from the cell than the amount of air which is being admitted through the inlettube F. While the valve G regulates the amount of air passing into the cell through the tube F, the latter also may serve as a medium for administering medicine to the patient in the cell by medicating air, if necessary, by passing it through a thin screen upon which a volatile medicament may be spread.
The cell or cabinet A may have a suitable barometer or gage E of any suitable nature for determining the atmospheric pressure Within the cell to facilitate regulation thereof in the customary manner.
Having thus described the invention, what is claimed as new is The herein-described rarefied-air apparatus for the treatment of pulmonary tuberculosis, comprising an air-tight cell or cabinet, an inlet-tube F extending through one wall of the cabinet and provided on its inner end with a hand-operatedvalve G whereby the flow of air into the cabinet may be regulated by the patient, the saidtube being designed to admit air into the cabinet, the outer end of said tube F being bell-shaped and being provided with a thin screen, and a volatile medicament spread upon said screen whereby the air admitted from said tube and controlled by said valve will be medicated as it passes to the patient, and an exhaling-tube D leading from the interior of the cabinet to the exterior atmosphere and being so located in the cabinet that it will be in convenient location for the patient to exhale the air therethrough that has been inhaled in the cabinet.
In testimony whereof I have signed my name to this specification in the presence of two subscribing Witnesses.
J. EDWARD HARPER. Witnesses J. WV. HARPER, JOHN W. MOORE.
US23376604A 1904-11-21 1904-11-21 Rarefied-air apparatus for the treatment of pulmonary tuberculosis. Expired - Lifetime US826029A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US23376604A US826029A (en) 1904-11-21 1904-11-21 Rarefied-air apparatus for the treatment of pulmonary tuberculosis.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23376604A US826029A (en) 1904-11-21 1904-11-21 Rarefied-air apparatus for the treatment of pulmonary tuberculosis.

Publications (1)

Publication Number Publication Date
US826029A true US826029A (en) 1906-07-17

Family

ID=2894509

Family Applications (1)

Application Number Title Priority Date Filing Date
US23376604A Expired - Lifetime US826029A (en) 1904-11-21 1904-11-21 Rarefied-air apparatus for the treatment of pulmonary tuberculosis.

Country Status (1)

Country Link
US (1) US826029A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188099A (en) * 1989-06-13 1993-02-23 Carlo Todeschini Therapeutic exercise chamber with controlled ozonated environment
US5306244A (en) * 1984-05-14 1994-04-26 Surgical Systems & Instruments, Inc. Method of guidewire insertion
US5799652A (en) * 1995-05-22 1998-09-01 Hypoxico Inc. Hypoxic room system and equipment for Hypoxic training and therapy at standard atmospheric pressure
USD430302S (en) * 1999-02-11 2000-08-29 Softub, Inc. Sauna enclosure
US6443148B1 (en) * 1998-07-28 2002-09-03 Hyperbaric Management Systems, Inc. Hyperbaric oxygen therapy system
US20020144683A1 (en) * 2001-02-28 2002-10-10 Hyperbaric Technology, Inc. Hyperbaric oxygen therapy system controls
US20040187680A1 (en) * 2000-09-06 2004-09-30 Colorado Altitude Training Llc Method and system for reducing body weight in an enclosed atmostpheric environment

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306244A (en) * 1984-05-14 1994-04-26 Surgical Systems & Instruments, Inc. Method of guidewire insertion
US5188099A (en) * 1989-06-13 1993-02-23 Carlo Todeschini Therapeutic exercise chamber with controlled ozonated environment
US5799652A (en) * 1995-05-22 1998-09-01 Hypoxico Inc. Hypoxic room system and equipment for Hypoxic training and therapy at standard atmospheric pressure
US6443148B1 (en) * 1998-07-28 2002-09-03 Hyperbaric Management Systems, Inc. Hyperbaric oxygen therapy system
USD430302S (en) * 1999-02-11 2000-08-29 Softub, Inc. Sauna enclosure
US20060225572A1 (en) * 2000-09-06 2006-10-12 Kutt Lawrence M Method and system for reducing body weight in an enclosed atmospheric environment
US20040187680A1 (en) * 2000-09-06 2004-09-30 Colorado Altitude Training Llc Method and system for reducing body weight in an enclosed atmostpheric environment
US7018443B2 (en) 2000-09-06 2006-03-28 Colorado Altitude Training Llc Method and system for reducing body weight in an enclosed atmospheric environment
US20020144683A1 (en) * 2001-02-28 2002-10-10 Hyperbaric Technology, Inc. Hyperbaric oxygen therapy system controls
US7263995B2 (en) 2001-02-28 2007-09-04 Hyperbaric Technology, Inc. Hyperbaric oxygen therapy system controls
US7360539B2 (en) 2001-02-28 2008-04-22 Hyperbaric Technology, Inc. Hyperbaric oxygen therapy system controls
US20080178877A1 (en) * 2001-02-28 2008-07-31 Hyperbaric Oxygen Therapy System Controls Safety Mechanism for Hyperbaric Oxygen Therapy System
US20080185003A1 (en) * 2001-02-28 2008-08-07 Hyperbaric Oxygen Therapy System Controls Safety mechanism for hyperbaric oxygen therapy system
US7900629B2 (en) 2001-02-28 2011-03-08 Hyperbaric Technology, Inc. Safety mechanism for hyperbaric oxygen therapy system
US8011470B2 (en) 2001-02-28 2011-09-06 Hyperbaric Technology, Inc. Compressor silencer for hyperbaric oxygen therapy system
US8899233B2 (en) 2001-02-28 2014-12-02 Hyperbaric Technology, Inc. Method for enabling transfer of an object from an interior of an airlock to a pressure vessel attached to the airlock

Similar Documents

Publication Publication Date Title
US6581600B2 (en) Interface apparatus and combination and method
Gross et al. Peripheral mucociliary clearance with high-frequency chest wall compression
Motley et al. Use of intermittent positive pressure breathing combined with nebulization in pulmonary disease
Tanner et al. The effects of three nebulized osmotic agents in the dry larynx
JPH0596007A (en) Revival device
JP2016506251A (en) System and method for providing non-invasive ventilation
JP2010524578A (en) Volume exchange valve system and method for increasing circulation during CPR
US10265495B2 (en) Pressure actuated valve systems and methods
US3511228A (en) Bronchial dilator for patients suffering from emphysema and asthma or the like
US826029A (en) Rarefied-air apparatus for the treatment of pulmonary tuberculosis.
US8540653B2 (en) Apparatus for mechanically ventilating a patient
US938247A (en) Breathing-mask.
US10729873B2 (en) T-device with one-way valve, flow-occlusion/release system, and pressure release valve
McConnell et al. Postoperative intermittent positive-pressure breathing treatments: Physiological considerations
Kshetry et al. Design and analysis of a low-cost electronically controlled mobile ventilator, incorporating mechanized AMBU bag, for patients during COVID-19 pandemic
Kunugiyama et al. High-frequency percussive ventilation using the VDR-4 ventilator: an effective strategy for patients with refractory hypoxemia
WO2016057847A1 (en) Percussive ventilator breathing head and system and method
US10124136B2 (en) Devices and methods for delivering air to a patient
Shikani et al. Experimental assessment and future applications of the Shikani tracheostomy speaking valve
VOLPITTO et al. INFLUENCE OF DIFFERENT FORMS OF MECHANICAL ARTIFICIAL RESPIRATION: ON THE PULMONARY AND SYSTEMIC BLOOD PRESSURE
Cooper Tracheostomy and controlled respiration
US119748A (en) Improvement in inhalers and vaporizers for administering anesthetics
US639808A (en) Inhaler.
FLEMING et al. A comparative evaluation of pressure-limited and volume-limited respirators for prolonged postoperative ventilatory support in combat casualties
CO2021011484A1 (en) Autonomous emergency system and method in a situation of respiratory arrest, for pulmonary resuscitation, through the use of a ventilation mask with a CO2 sensor, a self-regulated oxygen source and a cervical support